Recalls / Class II
Class IID-0043-2025
Product
Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98
- Affected lot / code info
- Lot # NB240316, Exp 12/31/25
Why it was recalled
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Recalling firm
- Firm
- Cipla USA, Inc.
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 10 Independence Blvd, N/A, Warren, New Jersey 07059-2730
Distribution
- Quantity
- 1,875 boxes (cipla and exlan)
- Distribution pattern
- USA nationwide.
Timeline
- Recall initiated
- 2024-10-23
- FDA classified
- 2024-11-12
- Posted by FDA
- 2024-11-20
- Status
- Ongoing
Source: openFDA Drug Enforcement endpoint. Recall record D-0043-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.